Posts

Showing posts with the label Cryptococcus market outlook

Cryptococcus – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Cryptococcus is an invasive fungus transmitted through the inhalation of spores that causes cryptococcosis, an infection commonly associated with immunosuppressive individuals. Patients present with headache, malaise, fever, photophobia and neck stiffness as cryptococcal meningitis sets in. The fungus capsule comprises polysaccharides glucuronoxylomannan and glucuronoxylomannogalactan, which significantly contribute to the pathogen's virulence. Infection is usually caused by inhaling spores from the environment. The initial condition is mostly asymptomatic and is contained in healthy individuals. The spread of the disease from the initial site of infection occurs through hematogenous dissemination in immune-suppressed patients. Another mechanism through which the condition can develop is the reactivation of the organism at the initial site of infection after several years when the patient becomes immunocompromised. In the United States, the incidence of cr...

Cryptococcus – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Cryptococcus is an invasive fungus transmitted through the inhalation of spores that causes cryptococcosis, an infection commonly associated with immunosuppressive individuals. Patients present with headache, malaise, fever, photophobia and neck stiffness as cryptococcal meningitis sets in. The fungus capsule comprises polysaccharides glucuronoxylomannan and glucuronoxylomannogalactan, which significantly contribute to the pathogen's virulence. Infection is usually caused by inhaling spores from the environment. The initial condition is mostly asymptomatic and is contained in healthy individuals. The spread of the disease from the initial site of infection occurs through hematogenous dissemination in immune-suppressed patients. Another mechanism through which the condition can develop is the reactivation of the organism at the initial site of infection after several years when the patient becomes immunocompromised. ·        In the United States, the...